FNY Investment Advisers’s CollPlant Biotechnologies CLGN Stock Holding History

FNY Investment Advisers’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Sell	5,250 -50	-0.9%	-$19	﹤0.01%	775
2026 Q1	$2K	Buy	5,300 +50	+1%	+$50	﹤0.01%	659
2025 Q4	$7K	Hold	5,250	–	–	﹤0.01%	697
2025 Q3	$14K	Buy	+5,250	New	+$12.5K	﹤0.01%	738
2024 Q1	–	Sell	-1,539	Closed	-$9K	–	694
2023 Q4	$9K	Hold	1,539	–	–	0.01%	317
2023 Q3	$8K	Hold	1,539	–	–	﹤0.01%	415
2023 Q2	$12K	Buy	+1,539	New	+$11.2K	0.02%	290
2022 Q4	–	Sell	-5,250	Closed	-$35K	–	540
2022 Q3	$35K	Buy	5,250 +250	+5%	+$2.03K	0.02%	253
2022 Q2	$40K	Hold	5,000	–	–	0.03%	253
2022 Q1	$57K	Buy	5,000 +3,000	+150%	+$33K	0.05%	229
2021 Q4	$32K	Sell	2,000 -2,000	-50%	-$35.7K	0.02%	282
2021 Q3	$67K	Hold	4,000	–	–	0.03%	283
2021 Q2	$84K	Sell	4,000 -6,000	-60%	-$95.9K	0.03%	306
2021 Q1	$134K	Buy	+10,000	New	+$151K	0.05%	254

Other funds holding CLGN

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

FNY Investment Advisers's CLGN Position: Q2 2026 in Review

FNY Investment Advisers reduced its CollPlant Biotechnologies (CLGN) stake by 0.94% in Q2 2026, selling an estimated $19 and leaving 5,250 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #775.

FNY Investment Advisers first reported a position in CLGN in Q1 2021 and has held it in 14 quarters since. The position peaked at $134K in Q1 2021. 2 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

FNY Investment Advisers held 5,250 shares of CollPlant Biotechnologies worth $1K as of Q2 2026.
FNY Investment Advisers sold 50 CollPlant Biotechnologies shares in Q2 2026, an estimated $19.
CollPlant Biotechnologies made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #775 holding.
FNY Investment Advisers first reported a position in CollPlant Biotechnologies in Q1 2021 and has held it in 14 quarters since.
FNY Investment Advisers's CollPlant Biotechnologies position peaked at $134K in Q1 2021.
2 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.